
Martin Dietrich, MD, PhD Medical Oncologist, Florida Hospital Cancer Institute, Orlando, Florida
Dr. Dietrich reviews FDA-approved and emerging biomarkers in NSCLC, and discusses the importance of a multidisciplinary approach and proper biopsy technique in facilitating a successful and timely molecular characterization of NSCLC
Case Study Patient Case: Biomarker Testing in Advanced NSCLC

Chung-Che (Jeff) Chang, MD, PhD A Case-Based Pathology Perspective on Biomarker Testing in NSCLC

Gaetane C. Michaud, MD A Case-Based Pulmonology Perspective on Biomarker Testing in NSCLC

Mark A. Socinski, MD A Case-Based Oncology Perspective on Biomarker Testing in NSCLC

Chung-Chee (Jeff) Chang, MD, PhD A Pathology Perspective on Biomarker Testing in NSCLC

Martin Dietrich, MD, PhD A Community Oncology Perspective on Biomarker Testing in NSCLC

Gaetane C. Michaud, MD A Pulmonology Perspective on Biomarker Testing in NSCLC

Mark A. Socinski, MD An Oncology Perspective on Biomarker Testing in NSCLC